Highlights From AASLD 2014: HCV Management

November 7-11, 2014; Boston, Massachusetts
In this Expert Analysis, Michael W. Fried, MD; David R. Nelson, MD; and Nancy Reau, MD, provide an in-depth review of the most clinically relevant new data presented at the 2014 American Association for the Study of Liver Disease conference on the management of HCV and other key topics, along with downloadable slides.
Michael W. Fried, MD
David R. Nelson, MD
Nancy Reau, MD
Physicians: maximum of 1.25 AMA PRA Category 1 Credits
Released: January 14, 2015 Expiration: January 13, 2016

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Integrate the results of recent clinical studies of approved HCV therapies into patient management strategies
  • Evaluate the impact of results of clinical studies of investigational treatments for chronic hepatitis C on future patient management strategies
  • Incorporate other practice-changing data regarding viral hepatitis or advanced liver disease into patient care

Acknowledgements

Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC
ACHS Logo

Annenberg Center for Health Sciences at Eisenhower
39000 Bob Hope Dr
Dinah Shore Bldg.
Rancho Mirage, CA 92270

Alma Perez, Accreditation Specialist
(760) 773-4506
(760) 773-4550 (Fax)
ce@annenberg.net
http://www.annenberg.net/

Produced in collaboration with
Educational grant provided by:
AbbVie
Gilead Sciences
Janssen Therapeutics

Information on this Educational Activity

Disclosure of Conflicts of Interest

The Annenberg Center assesses conflict of interest with its instructors, planners, managers, and other individuals who are in a position to control the content of CME activities. All relevant conflicts of interest that are identified are thoroughly vetted by the Annenberg Center for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. The Annenberg Center is committed to providing its learners with high-quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Faculty

Michael W. Fried, MD

Professor of Medicine
Director,
UNC Liver Center
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina

Michael W. Fried, MD, has disclosed that he has received funds for research support from AbbVie, Bristol-Myers Squibb, Genentech/Roche, Gilead Sciences, Merck, National Institutes of Health, Tibotec/Janssen, and Vertex and consulting fees from AbbVie, Bristol-Myers Squibb, Genentech/Roche, Gilead Sciences, GlaxoSmithKline, Merck, Novartis, Tibotec/Janssen, and Vertex.
David R. Nelson, MD

Professor of Medicine
Assistant Vice President for Research
University of Florida
Gainesville, Florida

David R. Nelson, MD, has disclosed that he has received funds for research support from AbbVie, Bristol-Myers Squibb, Gilead Sciences, Janssen, and Merck.
Nancy Reau, MD

Associate Professor of Medicine
Center for Liver Disease
University of Chicago
Chicago, Illinois

Nancy Reau, MD, has disclosed that she has received funds for research support from AbbVie, Boehringer Ingelheim, Bristol-Myers Squibb, and Gilead Sciences and consulting fees from AbbVie, Bristol-Myers Squibb, Gilead Sciences, Idenix, and Janssen.

Staff

Edward King, MA

Chief Innovation Officer

Edward King, MA, has no significant financial relationships to disclose.
Krista Marcello

Associate Managing Editor

Krista Marcello has no significant financial relationships to disclose.
Anna Poppa

Editorial Contributor

Anna Poppa has no significant financial relationships to disclose.
Jenny Schulz, PhD

Director, Scientific Services

Jenny Schulz, PhD, has no significant financial relationships to disclose.

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

The following planners and managers, Laura Excell, ND, NP, MS, MA, LPC, NCC; Trace Hutchison, PharmD; Samantha Mattiucci, PharmD, CCMEP; and Jan Schultz, RN, MSN, CCMEP hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

Charles E. Willis, Director of Continuing Education from the Annenberg Center for Health Sciences at Eisenhower consults for Pfizer, Inc.; Amanda Sewell, MBA, Manager of Continuing Education, Debbie Price, Database Administrative Secretary, and Alma Perez, Accreditation Specialist from the Annenberg Center for Health Sciences at Eisenhower have no relevant commercial relationships to disclose.

Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The Annenberg Center, Postgraduate Institute for Medicine (PIM), Clinical Care Options, and activity supporters do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the Annenberg Center, PIM, Clinical Care Options, and activity supporters. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Target Audience

This program is intended for physicians and other healthcare professionals involved in the care of patients with chronic hepatitis C.

Goal

The goal of this program is to identify the most clinically significant data from AASLD 2014 and translate those data to management strategies for patients with chronic hepatitis C.

Physician Continuing Medical Education

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC. The Annenberg Center for Health Sciences at Eisenhower is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation

The Annenberg Center for Health Sciences at Eisenhower designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Program Medium

This program has been made available online.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 1.25 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from January 14, 2015, through January 13, 2016:

1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 70% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.

Related Content

Expert overview of recommendations on the management of patients with HCV infection.

Stefan Zeuzem, MD
Program Director
Jordan J. Feld, MD, MPH Hemant Shah, MD, MScCH HPTE
Released: June 17, 2019

Alain H. Litwin, MD, provides expert insights on models of care that can expand linkage to HCV treatment and cure as well as contribute to overall improved health outcomes for persons who inject drugs.

Alain H. Litwin, MD Released: June 14, 2019

Watch this CME/CE video module from Clinical Care Options to learn important strategies for HCV elimination among people who are incarcerated

Mark S. Sulkowski, MD
Program Director
Matthew J. Akiyama, MD, MSc Debra Newman, PA-C, MPAS, MPH Anne Spaulding, MD, MPH
Physicians: maximum of 1.0 AMA PRA Category 1 Credit Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Released: June 6, 2019 Expiration: June 5, 2020

Downloadable slideset from CCO’s 2019 Hepatitis Symposium: Jordan J. Feld, MD, MPH, provides expert insights on how to simplify HCV management

Jordan J. Feld, MD, MPH Released: June 5, 2019

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?